CenterWatch
  • Search Clinical Trials
  • Clinical Trial Listings
  • Volunteer
  • Learn About Clinical Trials

Laragne Monteglin, France

< 2 Miles
Filters

Type

Distance
Age
0
0
Gender
Trial Phase
Sponsor
  • Product Surveillance Registry

    Phase

    N/A

    Span

    1466 weeks

    Sponsor

    Medtronic

    The Woodlands, Texas

    Recruiting

  • Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

    All Medtronic market-released leads and all market-released IPG, ICD and CRT devices are eligible to be included in this study.

    Phase

    N/A

    Span

    3027 weeks

    Sponsor

    Medtronic

    The Woodlands, Texas

    Recruiting

  • Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

    Phase

    3

    Span

    304 weeks

    Sponsor

    Gedeon Richter Plc.

    The Woodlands, Texas

    Recruiting

  • ML-004 in Adolescents and Adults with Autism Spectrum Disorders (ASD)

    Phase

    2

    Span

    220 weeks

    Sponsor

    MapLight Therapeutics

    The Woodlands, Texas

    Recruiting

  • A Real World, Observational Registry of Chronic Wounds and Ulcers

    This is a longitudinal, observational study of chronic wounds and ulcers treated at participating hospital based, outpatient wound centers. Data collection began in 2005. Structured data are collected at the point of care in the patient electronic health record and data from all patients at more than 100 wound centers in the USA and Puerto Rico are transmitted to the U.S. Wound Registry which is recognized by CMS as a Qualified Clinical Data Registry (QCDR). Participation in the USWR can satisfy the registry participation option for Stage 2 of Meaningful use. The dataset includes all wound and ulcer types such as diabetic foot ulcers, venous stasis ulcers, pressure ulcers, arterial ulcers, surgical wounds, traumatic wounds, vasculitic ulcers, arterial ulcers, sickle cell ulcers, inflammatory ulcers (e.g. pyoderma gangrenosum), and ulcers related to skin disorders such as scleroderma. Interventions provided include advanced dressings, compression bandaging, off-loading, cellular and/or tissue based therapies, hyperbaric oxygen therapy, negative pressure wound therapy, debridement, and antibiotics. Ulcers are risk stratified for outcomes reporting using the Wound Healing Index.Outcomes measured include healing or wound closure, surgical closure, death, and major and minor amputation. Data on wound care specific quality measures developed by the QCDR are also available.

    Phase

    N/A

    Span

    1100 weeks

    Sponsor

    U.S. Wound Registry

    The Woodlands, Texas

    Recruiting

  • Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    Phase

    3

    Span

    229 weeks

    Sponsor

    AbbVie

    The Woodlands, Texas

    Recruiting

  • A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

    Phase

    3

    Span

    309 weeks

    Sponsor

    AbbVie

    The Woodlands, Texas

    Recruiting

  • A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

    Phase

    3

    Span

    266 weeks

    Sponsor

    AbbVie

    The Woodlands, Texas

    Recruiting

  • RCT to Evaluate Social Skills in Children with Autism Using VR Technology (SoCaVR)

    The purpose of this study is to find out if Floreo's VR clinical program can help with autism symptoms such as social communication skills in autistic children. Recent advances in VR technology offers a new way to improve these types of skills in children with autism in an immersive and controlled environment. Questionnaires answered by adult caregivers will be used to assess the child's behaviors during the time of treatment. Clinician observations will also be conducted as a part of this study.

    Phase

    N/A

    Span

    55 weeks

    Sponsor

    Floreo, Inc.

    The Woodlands, Texas

    Recruiting

  • Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

    This is a randomized, double-blind, placebo-controlled, multicenter, 2-arm (1:1), parallel-group, efficacy and safety/tolerability fixed-dose study of SPN-812 in preschool-age children (4 to 5 years old) with ADHD. Participants will be screened for eligibility for up to 4 weeks. Eligible participants will be treated with study medication for 6 weeks. The total duration of the study is up to 10 weeks.

    Phase

    4

    Span

    94 weeks

    Sponsor

    Supernus Pharmaceuticals, Inc.

    The Woodlands, Texas

    Recruiting

1-10 of 10
CenterWatch

5000 Centregreen Way, Suite 200
Cary, NC, 27513, USA

Phone: 703.538.7600
Toll Free: 888.838.5578

  • Disclaimer
  • Privacy Policy
  • Term of Use
  • Do Not Sell My Personal Information